SVB Capital Management
PACB icon

SVB Capital Management’s Pacific Biosciences PACB Stock Holding History

SVB Capital Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$48.8K Hold
20,586
– – 0.01% 8
2026
Q2 		$34.6K Hold
20,586
– – 0.47% 6
2026
Q1 		$27.2K Hold
20,586
– – 1.31% 5
2025
Q4 		$38.5K Hold
20,586
– – 1.38% 5
2025
Q3 		$26.4K Hold
20,586
– – 0.08% 9
2025
Q2 		$25.5K Hold
20,586
– – 0.04% 11
2025
Q1 		$24.3K Hold
20,586
– – 0.07% 9
2024
Q4 		$37.7K Hold
20,586
– – 0.05% 9
2024
Q3 		$35K Buy
+20,586
New +$33.8K 0.03% 7

Other funds holding PACB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Capricorn Fund Managers
Capricorn Fund Managers London, United Kingdom $1.06B AUM 45.98% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Bourne Lent Asset Management
Bourne Lent Asset Management Pawling, New York $293M AUM 24.01% 1-Year Est. Return

SVB Capital Management's PACB Position: Q3 2026 in Review

SVB Capital Management held its Pacific Biosciences (PACB) position steady in Q3 2026 at 20,586 shares worth $48.8K. The position accounts for 0.01% of the portfolio, ranked #8.

SVB Capital Management first reported a position in PACB in Q3 2024 and has held it in 9 quarters since. 111 funds tracked by Wall St. Rank hold PACB as of Q3 2026.

  • SVB Capital Management held 20,586 shares of Pacific Biosciences worth $48.8K as of Q3 2026.
  • SVB Capital Management left its Pacific Biosciences share count unchanged in Q3 2026.
  • Pacific Biosciences made up 0.01% of SVB Capital Management's portfolio in Q3 2026, its #8 holding.
  • SVB Capital Management first reported a position in Pacific Biosciences in Q3 2024 and has held it in 9 quarters since.
  • 111 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.

Based on SVB Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.